Zydus wins US FDA approval for injectable vitamin C with exclusivity

Zydus wins US FDA approval for injectable vitamin C with exclusivity. The company received final approval for Ascorbic Acid Injection, granting it 180-day CGT exclusivity. This allows Zydus to launch the product before competitors, potentially capturing early market share. The approval strengthens its US generics portfolio.

📊 STOCKS: $ZYDUSLIFE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #FDAApproval